XML 45 R28.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE CAPITAL (Tables)
12 Months Ended
Dec. 31, 2022
SHARE CAPITAL  
Summary of Stock Option Activity

a)

Options granted to employees and directors:

Year Ended December 31, 2022

    

    

Weighted

Number

average

of

exercise

options

price

Outstanding at beginning of year

 

2,259,020

$

4.42

Changes during the year:

 

  

 

  

Granted

 

3,480,000

 

1.03

Forfeited and expired

 

219,705

 

4.62

Outstanding at end of year

 

5,519,315

$

2.28

Exercisable at end of year

 

1,731,434

$

4.25

Summary of Restricted Stock Activity

Year Ended December 31, 2022

Number of Restricted Stock

Outstanding at beginning of year

458,027

Changes during the year:

Granted

759,482

Vested

926,035

Non vested at end of year

291,474

Summary of Share Options Outstanding and Exercisable

December 31, 2022

Options outstanding

Options exercisable

    

Number of

    

Weighted

    

    

Weighted

options 

average

average

outstanding

remaining

Number of

remaining

Exercise

at end of

contractual

options

contractual

prices

year

life

exercisable

life

$1.03-$2.00

3,610,000

9.60

300,625

8.99

$3.55-$3.73

1,361,965

6.78

903,459

6.48

$4.69-$5.60

 

466,000

 

5.71

 

446,000

 

5.67

$17.20

 

81,350

 

2.10

 

81,350

 

2.10

 

5,519,315

 

1,731,434

Schedule of Stock Option Valuation Assumptions

Year Ended December 31, 

2020

2021

2022

Stock price (USD)

3.64

1.57

1.03

Exercise price (USD)

3.64

1.57

 

1.03

Risk free rate

0.74

%

0.88

%

3.32

%

Volatility

79.50

%

84.30

%

85.94

%

Dividend yield

0

%

0

%

0

%

Expected life (Years)

6

6

6

Schedule of Stock-Based Compensation Expense in Statement of Operations

Year Ended December 31, 

(U.S. dollars in thousands)

    

2020

    

2021

    

2022

Cost of goods sold

$

269

$

135

Research and development expenses

$

1,036

648

518

Selling, general and administrative expenses

 

2,090

 

1,458

 

1,432

$

3,126

$

2,375

$

2,085